Responses
Regular and Young Investigator Award Abstracts
Clinical Trial Completed
592 Updated recurrence free survival for neoadjuvant bintrafusp alfa (BA) for HPV unrelated HNSCC and results from BA plus a multitargeted recombinant adenovirus 5 vaccine for HPV unrelated HNSCC
Compose a Response to This Article
Other responses
No responses have been published for this article.